RAD adds brain tumor technology to portfolio
- Written by PR Newswire
 |
- Sublicensing of promising imaging & therapeutic radiopharmaceutical from leading US university, Case Western Reserve University (CWRU), Ohio
- PTPµ (PTPmu), the target, is a unique biomarker present only in tumor cells but not healthy cells
- The radionuclide carrying PTPµ-targeting agent holds the potential of first in class therapy in...
